When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome de Verner-Morrison (VIPoma)

Última revisão das evidências: 1 Sep 2026
Última atualização do tópico: 19 Dec 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • diarreia aquosa profusa
Detalhes completos

Outros fatores diagnósticos

  • aproximadamente 50 anos de idade
  • cefaleia
  • perda de peso
  • turgor cutâneo diminuído
  • membranas mucosas ressecadas
  • fraqueza muscular
  • cãibras musculares
  • sintomas gastrointestinais
  • sintomas de hiperglicemia
  • rubor
  • hepatomegalia
  • história de neoplasia endócrina múltipla tipo 1 (NEM1)
Detalhes completos

Fatores de risco

  • neoplasia endócrina múltipla tipo 1 (NEM1)
  • aproximadamente 50 anos de idade
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • potássio sérico
  • bicarbonato sérico
  • cálcio sérico
  • glicose sérica
  • radioimunoensaio do peptídeo intestinal vasoativo (PIV)
  • testes da função hepática
Detalhes completos

Investigações a serem consideradas

  • análise da gasometria arterial
  • monitoramento do potencial hidrogeniônico (pH) gástrico
  • cromogranina A
  • polipeptídeo pancreático
  • TC com contraste do abdome
  • ressonância nuclear magnética (RNM) com contraste do abdome
  • PET-TC/RNM com receptores da somatostatina
  • cintilografia com receptores da somatostatina
  • ultrassonografia endoscópica
  • exploração cirúrgica
  • ultrassonografia intraoperatória
  • biópsia
Detalhes completos

Algoritmo de tratamento

AGUDA

apresentação inicial do paciente sintomático

CONTÍNUA

doença localizada

Doença metastática: candidato a cirurgia

Doença metastática: não candidato a cirurgia

doença refratária

Colaboradores

Autores

Harish Lavu, MD, FACS
Harish Lavu

Professor of Surgery

Sidney Kimmel Medical College

Thomas Jefferson University

Philadelphia

PA

Declarações

HL declares that he has no competing interests.

Charles J. Yeo, MD, FACS
Charles J. Yeo

The Samuel D. Gross Professor and Chair

Department of Surgery

Sidney Kimmel Medical College

Thomas Jefferson University

Philadelphia

PA

Declarações

CJY declares that he has no competing interests.

Revisores

Alexandria Phan, MD

Professor of Medicine

Froedtert Hospital and the Medical College of Wisconsin

Milwaukee

WI

Declarações

AP declares that she has no competing interests.

Jonathan Strosberg, MD

Professor

Moffitt Cancer Center

Tampa

FL

Declarações

JS has consulted for Novartis and serves on the Speakers’ Bureau for Ipsen.

Jaime Ruiz-Tovar, MD

Fellow of the Spanish Association of Surgeons (AEC)

Department of Surgery

University Hospital Ramon y Cajal

Madrid

Spain

利益声明

JRT declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: neuroendocrine and adrenal tumors [internet publication].全文

Hofland J, Falconi M, Christ E, et al. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023 Aug;35(8):e13318.全文  摘要

Pavel M, Öberg K, Falconi M, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jul;31(7):844-60.全文

Del Rivero J, Perez K, Kennedy EB, et al. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. J Clin Oncol. 2023 Nov 10;41(32):5049-67.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Síndrome de Verner-Morrison (VIPoma) images
  • 鉴别诊断

    • Gastroenterite infecciosa
    • Diarreia osmótica
    • Má absorção do ácido biliar ileal
    更多 鉴别诊断
  • 指南

    • NCCN clinical practice guidelines in oncology: neuroendocrine and adrenal tumors
    • Symptom management for well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline
    更多 指南
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明